Bilateral Serous Maculopathy Associated with Acalabrutinib Therapy in Chronic Lymphocytic Leukemia
{{output}}
Purpose: To describe a case of bilateral central serous chorioretinopathy (CSC)-like maculopathy associated with Bruton's tyrosine kinase inhibitor acalabrutinib therapy in a patient with chronic lymphocytic leukemia (CLL). ... ...
